Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 21, 2012; 18(11): 1216-1228
Published online Mar 21, 2012. doi: 10.3748/wjg.v18.i11.1216
Published online Mar 21, 2012. doi: 10.3748/wjg.v18.i11.1216
Figure 5 Densitometric results from immunoblotting for three proteins describing potential associations of differential protein expression and clinical parameters.
The x-axis represents different clinical parameters and the y-axis represents relative band density. The P values are from the repeated measures analysis of variance. aP < 0.01 and bP < 0.05 are from the Bonferroni post-test. MRPL12: 39S ribosomal protein L12 (mitochondrial precursor); TPT1: Translationally controlled tumor protein; TALDO1: Transaldolase; N: Non-tumor; T: Tumor.
- Citation: Kočevar N, Odreman F, Vindigni A, Grazio SF, Komel R. Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers. World J Gastroenterol 2012; 18(11): 1216-1228
- URL: https://www.wjgnet.com/1007-9327/full/v18/i11/1216.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i11.1216